Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation. 2022

Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
School of Medicine, Nankai University, Tianjin 300071, China.

BACKGROUND High prevalence and reoccurrence rate of nephrolithiasis bring about serious socioeconomic and healthcare burden, necessitating the need of effective therapeutic agents. Previous study revealed that gallic acid (GAL) alters the nucleation pathway of calcium oxalate (CaOx). On the other hand, it appears protective role against oxidative injury. Whether GAL could protect against crystal-induced lesion in vivo, and its underlying mechanism is yet unsolved. OBJECTIVE This study aims to investigate the protective effects of GAL on the crystal-induced renal injury and its underlying mechanism in the mouse model of stone formation induced by glyoxylic acid. METHODS The mouse model of stone formation was established via successive intraperitoneal injection of glyoxylate. Proximal tubular epithelial cell line HK-2 treated with calcium oxalate monohydrate (COM) was used as in vitro model. The protective role of GAL on nephrolithiasis was tested by determination of tubular injury, crystal deposition and adhesion, levels of inflammatory cytokines, macrophage infiltration and the redox status of kidney. In vitro, effect of GAL on the ROS level and oxidative tubular injury induced by COM were detected, as well as major antioxidant pathway Nrf2/HO-1. RESULTS Administration of GAL alleviates the renal deposition and adhesion of CaOx stone. Meanwhile, GAL ameliorates the inflammation and renal tubular injury. Level of intracellular ROS, osteopontin and CD44 are reduced, either in the mouse model of stone formation or in the COM-treated HK-2 cells after treatment of GAL. Mechanistically, GAL activates Nrf2/HO-1 pathway in HK-2 cells. Silencing Nrf2 abrogates the protective effect of GAL on the oxidative injury and adhesion of COM in HK-2 cells. CONCLUSIONS Taken together, our study demonstrates the protective effect of GAL on the deposition of kidney stone and consequent tubular injury. Induction of the antioxidant pathway Nrf2/HO-1 was found to decrease the level of ROS and oxidative injury, thus implying that GAL could be a potential therapeutic agent for the treatment of nephrolithiasis.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D002129 Calcium Oxalate The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi. Calcium Oxalate (1:1),Calcium Oxalate Dihydrate,Calcium Oxalate Dihydrate (1:1),Calcium Oxalate Monohydrate,Calcium Oxalate Monohydrate (1:1),Calcium Oxalate Trihydrate,Dihydrate, Calcium Oxalate,Monohydrate, Calcium Oxalate,Oxalate, Calcium,Trihydrate, Calcium Oxalate
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005707 Gallic Acid A colorless or slightly yellow crystalline compound obtained from nutgalls. It is used in photography, pharmaceuticals, and as an analytical reagent. 3,4,5-Trihydroxybenzoic Acid,Acid, Gallic
D006038 Glyoxylates Derivatives of glyoxylic acid (the structural formula C2H2O3), including its salts and esters.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D051267 NF-E2-Related Factor 2 A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage. Nfe2l2 Protein,Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein,Nuclear Factor E2-Related Factor 2,NF E2 Related Factor 2,Nuclear Factor E2 Related Factor 2

Related Publications

Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
May 2023, Archives of biochemistry and biophysics,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
January 2019, Dose-response : a publication of International Hormesis Society,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
February 2023, Radiation research,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
January 2022, Drug design, development and therapy,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
August 2022, Molecular medicine reports,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
February 2008, International journal of urology : official journal of the Japanese Urological Association,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
May 2019, Journal of cellular biochemistry,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
July 2019, The Journal of urology,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
January 2019, Phytotherapy research : PTR,
Donghui Zhou, and Yan Wu, and Heng Yan, and Tianyu Shen, and Si Li, and Junbo Gong, and Gang Li, and Haixing Mai, and Dekun Wang, and Xiaoyue Tan
March 2020, Environmental science and pollution research international,
Copied contents to your clipboard!